Oskar Hansson comments on research supporting earlier treatment with anti-amyloid monoclonal antibodies and the importance of amyloid PET imaging for monitoring patients, with the potential to treat less often.
Oskar Hansson comments on research supporting earlier treatment with anti-amyloid monoclonal antibodies and the importance of amyloid PET imaging for monitoring patients, with the potential to treat less often.
Contact us: ime@springer.com
This activity is supported by an educational grant from Lilly.
This content was last updated on 3rd March 2024
Follow Us:
Manage cookie preferences
© 2024 Springer Healthcare Ltd | Website by Arttia Creative
